• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用循环肿瘤细胞分析的癌症治疗前景

Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells.

作者信息

Jeong Keun-Yeong, Kim Eun Kyung, Park Min Hee, Kim Hwan Mook

机构信息

R&D Division, Metimedi Pharmaceuticals Co., 263, Central-ro, Yeonsu-Gu, Incheon 22006, Korea.

Gachon Institute of Pharmaceutical Science, Gachon University, 191, Hambangmoe-ro, Yeonsu-gu, Incheon 21936, Korea.

出版信息

Diagnostics (Basel). 2018 Apr 11;8(2):23. doi: 10.3390/diagnostics8020023.

DOI:10.3390/diagnostics8020023
PMID:29641512
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6023425/
Abstract

Various methods are available for cancer screening, and the methods are performed depending on the origin site of cancer. Among these methods, biopsy followed by medical imaging is the most common. After cancer progression is determined, an optimal treatment-such as surgery, chemotherapy, and/or radiation therapy-is selected. A new assay has been developed that detects circulating tumor cells (CTCs). Tracking changes in CTCs may reveal important tumoral sensitivity information or resistance patterns to specific regimens and prompt changes in therapy on a personalized basis. Characterization of CTCs at the DNA, RNA, and protein levels is important for gaining insight for clinical applications. A small number of CTCs can be analyzed to obtain genome information such as the progression of cancer including metastasis, even in a single cluster. Although many clinical studies, particularly CTC enumeration and detection of specific oncogene expression, have increased the success rate of diagnosis and predicting prognosis, there is no consensus regarding the technical approaches and various aspects of the methodology, making it difficult to standardize optimal methods for CTC analysis. However, ongoing technological advances are currently being achieved and large-scale clinical studies are being conducted. Applying CTC analysis in the clinic would be very useful for advancing diagnosis, prognosis prediction, and therapeutics.

摘要

有多种癌症筛查方法,这些方法根据癌症的起源部位进行。在这些方法中,活检后进行医学成像最为常见。确定癌症进展后,选择最佳治疗方法,如手术、化疗和/或放疗。一种检测循环肿瘤细胞(CTC)的新检测方法已经开发出来。追踪CTC的变化可能会揭示重要的肿瘤敏感性信息或对特定治疗方案的耐药模式,并促使个性化治疗方案的改变。在DNA、RNA和蛋白质水平对CTC进行表征对于临床应用的深入了解很重要。即使在单个簇中,也可以分析少量的CTC以获得基因组信息,如癌症进展包括转移情况。尽管许多临床研究,特别是CTC计数和特定癌基因表达的检测,提高了诊断成功率和预后预测能力,但在技术方法和方法的各个方面尚未达成共识,这使得难以标准化CTC分析的最佳方法。然而,目前正在取得持续的技术进步,并正在进行大规模临床研究。在临床中应用CTC分析对于推进诊断、预后预测和治疗将非常有用。

相似文献

1
Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells.利用循环肿瘤细胞分析的癌症治疗前景
Diagnostics (Basel). 2018 Apr 11;8(2):23. doi: 10.3390/diagnostics8020023.
2
Longitudinal enumeration and cluster evaluation of circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial.前瞻性观察性试验中,对循环肿瘤细胞进行纵向计数和聚类评估可改善新诊断转移性乳腺癌患者的预后。
Breast Cancer Res. 2018 Jun 8;20(1):48. doi: 10.1186/s13058-018-0976-0.
3
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.前瞻性观察队列中转移性乳腺癌患者系列血样中循环肿瘤细胞凋亡及簇集的预后影响
BMC Cancer. 2016 Jul 8;16:433. doi: 10.1186/s12885-016-2406-y.
4
The Potential Clinical Implications of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.循环肿瘤细胞和循环肿瘤微栓在胃癌中的潜在临床意义。
Oncologist. 2019 Sep;24(9):e854-e863. doi: 10.1634/theoncologist.2018-0741. Epub 2019 Mar 7.
5
Circulating tumor cells as biomarkers in head and neck cancer: recent advances and future outlook.循环肿瘤细胞作为头颈部癌症的生物标志物:最新进展和未来展望。
Expert Rev Mol Diagn. 2018 Oct;18(10):897-906. doi: 10.1080/14737159.2018.1522251. Epub 2018 Sep 21.
6
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib.评估非小细胞肺癌中的循环肿瘤细胞和循环肿瘤 DNA:在曲妥珠单抗和厄洛替尼的 II 期临床试验中与临床终点的关联。
Clin Cancer Res. 2012 Apr 15;18(8):2391-401. doi: 10.1158/1078-0432.CCR-11-3148. Epub 2012 Apr 5.
7
The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.基于上皮-间充质转化标志物的循环肿瘤细胞表型检测在 HER2 阴性转移性乳腺癌一线化疗中的预后和治疗意义。
Cancer Commun (Lond). 2019 Jan 3;39(1):1. doi: 10.1186/s40880-018-0346-4.
8
Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.基于循环肿瘤细胞(CTC)特征的个体化乳腺癌治疗方法。
Cancer Treat Rev. 2013 Nov;39(7):691-700. doi: 10.1016/j.ctrv.2013.04.001. Epub 2013 May 16.
9
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy.循环肿瘤细胞和循环肿瘤 DNA 作为液体活检的临床应用。
Cancer Discov. 2016 May;6(5):479-91. doi: 10.1158/2159-8290.CD-15-1483. Epub 2016 Mar 11.
10
Prospective assessment of the prognostic value of circulating tumor cells and their clusters in patients with advanced-stage breast cancer.晚期乳腺癌患者循环肿瘤细胞及其簇的预后价值的前瞻性评估。
Breast Cancer Res Treat. 2015 Dec;154(3):563-71. doi: 10.1007/s10549-015-3636-4. Epub 2015 Nov 16.

引用本文的文献

1
Advancement of single-cell sequencing for clinical diagnosis and treatment of pancreatic cancer.单细胞测序在胰腺癌临床诊断与治疗中的进展
Front Med (Lausanne). 2023 Aug 31;10:1213136. doi: 10.3389/fmed.2023.1213136. eCollection 2023.
2
The Crosstalk Between Immune Infiltration, Circulating Tumor Cells, and Metastasis in Pancreatic Cancer: Identification of HMGB3 From a Multiple Omics Analysis.胰腺癌中免疫浸润、循环肿瘤细胞与转移之间的相互作用:通过多重组学分析鉴定HMGB3
Front Genet. 2022 Jun 8;13:892177. doi: 10.3389/fgene.2022.892177. eCollection 2022.
3
GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer.GAS2L1是胰腺癌循环肿瘤细胞的潜在生物标志物。
Cancers (Basel). 2020 Dec 15;12(12):3774. doi: 10.3390/cancers12123774.
4
Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells.通过对罕见循环肿瘤细胞进行计数来早期检测癌症的CellMax平台的分析验证。
J Circ Biomark. 2019 Dec 31;8:1849454419899214. doi: 10.1177/1849454419899214. eCollection 2019 Jan-Dec.
5
Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival.胰腺导管腺癌患者循环肿瘤细胞的表达谱分析:预测总生存期的生物标志物
Front Oncol. 2019 Sep 10;9:874. doi: 10.3389/fonc.2019.00874. eCollection 2019.
6
Prospective multicenter real-world RAS mutation comparison between OncoBEAM-based liquid biopsy and tissue analysis in metastatic colorectal cancer.基于 OncoBEAM 的液体活检与组织分析在转移性结直肠癌中的前瞻性多中心真实世界 RAS 突变比较。
Br J Cancer. 2018 Dec;119(12):1464-1470. doi: 10.1038/s41416-018-0293-5. Epub 2018 Nov 23.

本文引用的文献

1
Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.循环肿瘤细胞衍生类器官:医学研究和精准医疗中的当前挑战与前景。
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):117-127. doi: 10.1016/j.bbcan.2017.12.005. Epub 2018 Jan 31.
2
Circulating tumor cells: silent predictors of metastasis.循环肿瘤细胞:转移的隐匿预测指标
F1000Res. 2017 Aug 14;6. doi: 10.12688/f1000research.11313.1. eCollection 2017.
3
Fiber-Optic Array Scanning Technology (FAST) for Detection and Molecular Characterization of Circulating Tumor Cells.用于循环肿瘤细胞检测和分子特征分析的光纤阵列扫描技术(FAST)
Methods Mol Biol. 2017;1634:235-246. doi: 10.1007/978-1-4939-7144-2_20.
4
Breast Cancer Screening for High-Risk Patients of Different Ages and Risk - Which Modality Is Most Effective?针对不同年龄和风险的高危乳腺癌患者进行筛查——哪种方式最有效?
Cureus. 2016 Dec 28;8(12):e945. doi: 10.7759/cureus.945.
5
Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests.目前用于结直肠癌筛查的非侵入性检测:结直肠癌筛查检测概述
World J Gastrointest Oncol. 2016 Nov 15;8(11):793-800. doi: 10.4251/wjgo.v8.i11.793.
6
Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.循环肿瘤细胞作为前列腺癌、膀胱癌和肾癌的生物标志物。
Nat Rev Urol. 2017 Feb;14(2):90-97. doi: 10.1038/nrurol.2016.224. Epub 2016 Nov 22.
7
UDP-N-acetyl-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase- 6 (pp-GalNAc-T6): Role in Cancer and Prospects as a Drug Target.UDP-N-乙酰-D-半乳糖胺:多肽N-乙酰半乳糖胺基转移酶-6(pp-GalNAc-T6):在癌症中的作用及作为药物靶点的前景
Curr Cancer Drug Targets. 2017;17(1):53-61. doi: 10.2174/1568009616666160922102641.
8
MINDEC-An Enhanced Negative Depletion Strategy for Circulating Tumour Cell Enrichment.MINDEC:一种增强型负性耗竭策略,用于循环肿瘤细胞富集。
Sci Rep. 2016 Jul 19;6:28929. doi: 10.1038/srep28929.
9
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
10
Gene expression analysis of bone metastasis and circulating tumor cells from metastatic castrate-resistant prostate cancer patients.转移性去势抵抗性前列腺癌患者骨转移和循环肿瘤细胞的基因表达分析
J Transl Med. 2016 Mar 15;14:72. doi: 10.1186/s12967-016-0829-5.